| Quarterly Financials | Mar 2025 | Dec 2025 | Mar 2026 |
Revenue  | 49 | 36 | 51 |
| Expenses | 32 | 23 | 36 |
| EBITDA | 17 | 13 | 15 |
| Operating Profit % | 35 % | 35 % | 30 % |
| Depreciation | 1 | 0 | 0 |
| Interest | 1 | 2 | 1 |
| Profit Before Tax | 16 | 11 | 14 |
| Tax | -1 | 6 | 3 |
| Net Profit | 17 | 5 | 11 |
| EPS in ₹ | 5.15 | 1.13 | 2.33 |
Anlon Healthcare
Anlon Healthcare
13.98
-0.15
(-1.06%)
Market Cap
743.06 Cr
PE Ratio
25.76
Volume
50,62,948.00
Day High - Low
14.64 - 13.90
52W High-Low
172.75 - 9.08
Key Fundamentals
Market Cap
743.06 Cr
EPS
5.93
PE Ratio
25.76
PB Ratio
3.27
Book Value
4.33
EBITDA
46.14
Dividend Yield
0.00 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
25.51
Debt to Equity
1.46
Actual
Company News
View All News
Anlon Healthcare Limited will hold an earnings conference call on June 03, 2026, to discuss audited financial results for Q4 and FY26. The meeting is scheduled for 04:00 PM IST.
Anlon Healthcare Board Meet on May 29
May 23, 2026
May 23, 2026Anlon Healthcare Limited has scheduled a board meeting for May 29, 2026, to consider and approve the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026.
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,782.20 | #1 4,27,609.48 | 37.09 | #1 58,220.10 | 6.38 | #1 11,565 | 25.80 | 43.33 | |
6,623.00 | 1,75,819.84 | 68.17 | 10,560.00 | 8.73 | 2,520 | 13.44 | 49.66 | |
4,420.90 | 1,49,623.34 | 68.66 | 13,886.20 | 20.34 | 2,138 | -26.91 | 53.32 | |
1,401.30 | 1,13,194.31 | 29.24 | 27,711.70 | -2.46 | 3,783 | -55.32 | 58.57 | |
1,089.00 | 1,09,578.88 | 21.32 | 26,719.70 | 13.65 | 5,242 | 7.82 | 71.01 | |
1,278.20 | 1,06,684.07 | 25.44 | 33,593.30 | -0.44 | 3,998 | -86.05 | 45.82 | |
2,267.70 | 1,03,643.69 | #1 19.20 | 27,487.50 | 19.98 | 5,345 | #1 87.72 | 47.04 | |
2,336.10 | 96,435.39 | 50.16 | 14,277.60 | 12.03 | 1,750 | 31.75 | 47.08 | |
1,462.30 | 84,930.62 | 24.27 | 33,384.70 | 3.21 | 3,376 | 1.99 | 53.78 | |
1,446.80 | 78,106.45 | 86.55 | 6,812.90 | #1 21.03 | 884 | 21.18 | 80.98 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
46.47 %
Net Income Growth
42.83 %
Cash Flow Change
-598.14 %
ROE
-44.45 %
ROCE
43.74 %
EBITDA Margin (Avg.)
-2.90 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 71 | 85 | 112 | 128 | 181 | 317 |
| Fixed Assets | 29 | 27 | 26 | 27 | 23 | 40 |
| Current Assets | 40 | 58 | 86 | 101 | 159 | 260 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 2 | 4 | 1 | 1 | 76 |
| Other Assets | 43 | 56 | 82 | 100 | 158 | 0 |
| Total Equity & Liabilities | 71 | 85 | 112 | 128 | 181 | 317 |
| Current Liabilities | 31 | 29 | 44 | 50 | 60 | 101 |
| Non Current Liabilities | 38 | 55 | 61 | 57 | 41 | 7 |
| Total Equity | 2 | 2 | 7 | 21 | 80 | 210 |
| Reserve & Surplus | -10 | -10 | -5 | 5 | 41 | 157 |
| Share Capital | 12 | 12 | 12 | 16 | 40 | 53 |
Cash Flow
| Cash Flow | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -2 | 1 | -1 | 2 | -1 |
| Investing Activities | -3 | -0 | -0 | -3 | 3 |
| Operating Activities | -15 | -2 | -3 | -3 | -23 |
| Financing Activities | 16 | 3 | 2 | 8 | 19 |
Share Holding
| % Holding | Oct 2024 | Apr 2025 | Jun 2025 | Aug 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
| Promoter | 70.26 % | 70.26 % | 52.68 % | 70.26 % | 52.68 % | 52.68 % | 52.68 % |
| FIIs | 0.00 % | 0.00 % | 14.42 % | 0.00 % | 0.00 % | 0.23 % | 0.32 % |
| DIIs | 0.00 % | 0.00 % | 4.35 % | 0.00 % | 2.83 % | 4.49 % | 4.60 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 0.00 % | 14.64 % | 0.00 % | 20.73 % | 23.58 % | 24.38 % |
| Others | 29.74 % | 29.74 % | 13.92 % | 29.74 % | 23.75 % | 19.02 % | 18.02 % |
| No of Share Holders | 109 | 131 | 9,125 | 135 | 9,126 | 11,412 | 12,484 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 11 Nov 2025 |  Quarterly Result Announcement | NA | 11 Nov 2025 | 13.91 | 142.50 |
| 09 Feb 2026 | Quarterly Result Announcement | NA | 09 Feb 2026 | 12.01 | 12.53 |
| 24 Apr 2026 |  Bonus | 1:1 | 24 Apr 2026 | 12.19 | 14.38 |
| 06 Mar 2026 |  Split | 2:10 | 24 Apr 2026 | 11.19 | 11.19 |
| 29 May 2026 | Quarterly Result Announcement | NA | 29 May 2026 | 13.89 | 14.23 |
Announcements
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome2 days ago
2 days agoAnnouncement under Regulation 30 (LODR)-Investor Presentation2 days ago
2 days agoAnnouncement under Regulation 30 (LODR)-Newspaper Publication6 days ago
6 days agoAnnouncement under Regulation 30 (LODR)-Press Release / Media Release6 days ago
6 days agoConsidered Approved And Taken On Record Audited Financial Results For The Quarter And Year Ended 31St March 20267 days ago
7 days agoBoard Meeting Outcome for To Consider And Approve Financial Results For The Quarter And Year Ended March 31 20267 days ago
7 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation8 days ago
8 days agoBoard Meeting Intimation for To Consider And Approve The Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Financial Year Ended March 31 2026 Along With The Auditors Report Thereon.May 23, 2026
May 23, 2026Announcement under Regulation 30 (LODR)-Monitoring Agency ReportMay 13, 2026
May 13, 2026Updates On AcquisitionMay 08, 2026
May 08, 2026Announcements Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Apr 27, 2026
Apr 27, 2026Announcement under Regulation 30 (LODR)-AllotmentApr 27, 2026
Apr 27, 2026Intimation Of New ISINApr 22, 2026
Apr 22, 2026Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsApr 16, 2026
Apr 16, 2026Board Meeting Outcome for For Entered Into Share Purchase Agreement With Remember India Health Links Private LimitedApr 16, 2026
Apr 16, 2026Announcement under Regulation 30 (LODR)-Credit RatingApr 15, 2026
Apr 15, 2026Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 15, 2026
Apr 15, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 10, 2026
Apr 10, 2026Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of AssociationApr 09, 2026
Apr 09, 2026Corporate Action-Board recommends Bonus IssueApr 09, 2026
Apr 09, 2026Corporate Action-updates on Outcome of Sub division / Stock SplitApr 09, 2026
Apr 09, 2026 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportApr 08, 2026
Apr 08, 2026Closure of Trading WindowMar 25, 2026
Mar 25, 2026Announcement under Regulation 30 (LODR)-Updates on AcquisitionMar 20, 2026
Mar 20, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 18, 2026
Mar 18, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 12, 2026
Mar 12, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationMar 11, 2026
Mar 11, 2026Shareholder Meeting / Postal Ballot-Notice of Postal BallotMar 09, 2026
Mar 09, 2026Corporate Action-Board to consider Bonus IssueMar 06, 2026
Mar 06, 2026Corporate Action-Intimation of Sub division / Stock SplitMar 06, 2026
Mar 06, 2026Board Meeting Outcome for Outcome Of Board Meeting Of Anlon Healthcare Limited Held On Friday March 06 2026Mar 06, 2026
Mar 06, 2026Closure of Trading WindowMar 02, 2026
Mar 02, 2026Board Meeting Intimation for Stock Split And Issue Of Bonus SharesMar 02, 2026
Mar 02, 2026Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsFeb 27, 2026
Feb 27, 2026Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 24, 2026
Feb 24, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 19, 2026
Feb 19, 2026Announcement under Regulation 30 (LODR)-Investor PresentationFeb 19, 2026
Feb 19, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 13, 2026
Feb 13, 2026Announcement under Regulation 30 (LODR)-Monitoring Agency ReportFeb 12, 2026
Feb 12, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 11, 2026
Feb 11, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 10, 2026
Feb 10, 2026Approval Of Appointment Of Mr. Naimish Dilipbhai Bhatt As A Chief Financial Officer Of The Company.Feb 09, 2026
Feb 09, 2026Approval Of Resignation Of Mr. Shailesh Kantilal Thakkar Independent Director Of The Company.Feb 09, 2026
Feb 09, 2026Appointment Of Mr. Kishan Vinodkumar Raja As A Independent DirectorFeb 09, 2026
Feb 09, 2026Announcement under Regulation 30 (LODR)-Resignation of DirectorFeb 09, 2026
Feb 09, 2026Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)Feb 09, 2026
Feb 09, 2026Anlon Helthcare Limited_Financial Results For The Quarter Ended December 31 2025Feb 09, 2026
Feb 09, 2026Board Meeting Outcome for Outcome Of Board Meeting For The Approval Of Financial Results For The Quarter Ended December 31 2025Feb 09, 2026
Feb 09, 2026The Company Has Purchased A Commercial Office At Ahmedabad Gujarat And Shall Be Used For Marketing Office.Feb 05, 2026
Feb 05, 2026Board Meeting Intimation for Consideration And Approve The Financial Results For The Quarter Ended December 31 2025
Feb 03, 2026
Feb 03, 2026Technical Indicators
RSI(14)
Neutral 57.13
ATR(14)
Volatile 0.78
STOCH(9,6)
Neutral 36.35
STOCH RSI(14)
Neutral 38.77
MACD(12,26)
Bearish -0.01
ADX(14)
Strong Trend 28.84
UO(9)
Bearish 34.98
ROC(12)
Uptrend And Accelerating 4.74
WillR(14)
Neutral -52.86
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
